R16L (p.Arg16Leu) variant of DSP (Desmoplakin)

R16L (p.Arg16Leu) in DSP (Desmoplakin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.52 / 1. The record also includes population frequency data and structural context.

R16L (p.Arg16Leu) variant details